HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wengen Wu Selected Research

Therapeutics

11/2014Sphingosine kinase 1 isoform-specific interactions in breast cancer.
5/2014A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccines.
10/2013A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wengen Wu Research Topics

Disease

5Neoplasms (Cancer)
11/2023 - 04/2011
2Rhabdomyosarcoma
05/2014 - 10/2013
2Carcinoma (Carcinomatosis)
05/2014 - 05/2013
1Hepatocellular Carcinoma (Hepatoma)
11/2021
1Body Weight (Weight, Body)
01/2019
1Weight Gain
01/2019
1Tuberculosis (Tuberculoses)
04/2015
1Breast Neoplasms (Breast Cancer)
11/2014
1Fowlpox
05/2014
1Vaccinia
05/2014
1Sarcoma (Soft Tissue Sarcoma)
10/2013
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2013
1Multiple Myeloma
07/2011
1Type 2 Diabetes Mellitus (MODY)
10/2008

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
11/2023 - 05/2013
3Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
11/2023 - 10/2013
3EnzymesIBA
05/2014 - 01/2013
2Boronic AcidsIBA
11/2023 - 07/2011
2Peptide Hydrolases (Proteases)FDA Link
04/2015 - 07/2011
2AntigensIBA
05/2014 - 10/2013
2Cancer VaccinesIBA
05/2014 - 10/2013
2VaccinesIBA
05/2014 - 10/2013
2ARI-4175IBA
05/2014 - 10/2013
2Serine Proteases (Serine Protease)IBA
05/2013 - 10/2008
1LigandsIBA
11/2023
1quinolineIBA
11/2023
1Prolyl OligopeptidasesIBA
11/2023
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
11/2023
1InflammasomesIBA
11/2021
1Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA
11/2021
1Messenger RNA (mRNA)IBA
11/2021
1LipidsIBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1sphingosine kinaseIBA
11/2014
1Myristoylated Alanine-Rich C Kinase SubstrateIBA
11/2014
1Protein Isoforms (Isoforms)IBA
11/2014
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
05/2014
1ProdrugsIBA
07/2011
1Bortezomib (Velcade)FDA Link
07/2011
1ATP dependent 26S protease (26S proteasome)IBA
07/2011
1Proteasome InhibitorsIBA
07/2011
1Antineoplastic Agents (Antineoplastics)IBA
04/2011
1Hypoglycemic Agents (Hypoglycemics)IBA
04/2011
1IncretinsIBA
10/2008
1Hormones (Hormone)IBA
10/2008
1Glucagon-Like Peptide 1 (GLP 1)IBA
10/2008

Therapy/Procedure

3Therapeutics
11/2014 - 10/2013
1Precision Medicine
11/2023
1Immunotherapy
05/2014
1Drug Therapy (Chemotherapy)
10/2013
1Cell- and Tissue-Based Therapy (Cell Therapy)
10/2013